broad-genus claims in this space are already being chipped away at the patent offices
However, starting July 1, 2026, a temporary program called the Medicare GLP-1 Bridge will provide limited coverage to some weight loss drugs
This reveals whether your plateau is driven by GLP1R adaptation, GIPR insensitivity, or metabolic factors, guiding your clinician to select the most effective protocol adjustment or alternative medication for your genetics
The salicylate component can increase methotrexate toxicity, so this combination should be avoided
2024;47:1871888 Ghosh P, Fontanella RA, Scisciola L, Pesapane A, Taktaz F, Franzese M, et al
Some patients may benefit from slower titration or remaining at a lower effective dose